LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality biosimilars, announced today that the ...
Fresenius Kabi's plant on Grand Island has a slogan: Saving lives one vial at a time. The plant, which employs about 800 people, makes sterile, injectable pharmaceuticals, used in doctors' offices ...
The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...
der Fresenius eine hohe Verschuldung brachte. Vorstandschef Sen konzentriert sich auf nur zwei Sparten – den Arznei- und Medizintechnikhersteller Kabi und Europas größte Klinikgesellschaft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback